Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. News
  7. Summary
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Report
Real-time Euronext Bruxelles  -  05:05 2022-10-04 am EDT
6.430 EUR   +1.42%
03:42aMithra Pharmaceuticals S A : releases invitation to its extraordinary securities holders' meeting
PU
09/27Mithra Pharmaceuticals S A : Conversion of a portion of the loans from Highbridge and Whitebox
PU
09/27Mithra Pharmaceuticals S A : 2022 Half Year Results
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mithra Pharmaceuticals S A : 2021 Full Year Results

08/17/2022 | 09:44am EDT
Mithra 2021 Full Year Results
Subscribe

17 Aug 2022 15:31 CEST

Company Name

MITHRA

ISN

BE0974283153

Market

Euronext

Symbol

MITRA

Source

MITHRA

Provider

Euronext

Disclaimer

Mithra Pharmaceuticals SA published this content on 17 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2022 13:43:06 UTC.


© Publicnow 2022
All news about MITHRA PHARMACEUTICALS S.A.
03:42aMithra Pharmaceuticals S A : releases invitation to its extraordinary securities holders' ..
PU
09/27Mithra Pharmaceuticals S A : Conversion of a portion of the loans from Highbridge and Whit..
PU
09/27Mithra Pharmaceuticals S A : 2022 Half Year Results
PU
09/23Mithra Pharmaceuticals SA Reports Earnings Results for the Half Year Ended June 30, 202..
CI
09/23Transcript : Mithra Pharmaceuticals SA, H1 2022 Earnings Call, Sep 23, 2022
CI
09/23Mithra Pharmaceuticals S A : Half Year 2022 Results
PU
09/23Mithra Pharmaceuticals S A : Announces 2022 Half Year Results
PU
09/23MITHRA PHARMACEUTICALS S.A. : 1st-half-year results
CO
09/23MITHRA PHARMACEUTICALS S.A. : Half-year report
CO
09/21Mithra and Lotus announce approval of ALYSSA, an innovative oral contraceptive, in both..
AQ
More news
Financials
Sales 2022 172 M 169 M 169 M
Net income 2022 84,7 M 83,3 M 83,3 M
Net Debt 2022 266 M 262 M 262 M
P/E ratio 2022 3,70x
Yield 2022 -
Capitalization 336 M 330 M 330 M
EV / Sales 2022 3,51x
EV / Sales 2023 3,88x
Nbr of Employees 300
Free-Float 65,9%
Chart MITHRA PHARMACEUTICALS S.A.
Duration : Period :
Mithra Pharmaceuticals S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MITHRA PHARMACEUTICALS S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 6,34 €
Average target price 24,70 €
Spread / Average Target 290%
EPS Revisions
Managers and Directors
Leon van Rompay Chief Executive Officer
Christophe Maréchal Chief Financial Officer
Christian Moretti Chairman
Graham K. Dixon CSO, Head-Research & Development
Koen Hoffman Independent Director
Sector and Competitors